Related Experiment Video
Updated: Aug 19, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Migraine headache relief after transcatheter closure of patent foramen ovale
Mark Reisman1, Ryan D Christofferson, Jill Jesurum
1Cardiovascular Research, Swedish Medical Center.
Objectives:
The purpose of this study was to determine the effects of transcatheter patent foramen ovale (PFO) closure on migraine frequency in patients with paradoxical cerebral embolism.
Background:
The prevalence of migraine headache is higher in cryptogenic stroke patients with PFO than in the general population. Previous studies have suggested that closure of the PFO may reduce migrainous symptoms.
Methods:
Between April 2001 and December 2003, 162 consecutive patients with paradoxical cerebral embolism underwent transcatheter PFO closure for prevention of recurrent cryptogenic stroke or transient ischemic attack. A one-year retrospective analysis of migraine symptoms before and after PFO closure was performed.
Results:
Active migraine was present in 35% (57 of 162) of patients, and 68% (39 of 57) experienced migrainous aura; 50 patients were available for analysis at one year. Complete resolution of migraine symptoms occurred in 56% (28 of 50) of patients, and 14% (7 of 50) of patients reported a significant (>or=50%) reduction in migraine frequency. Patients reported an 80% reduction in the mean number of migraine episodes per month after PFO closure (6.8 +/- 9.6 before closure vs. 1.4 +/- 3.4 after closure, p < 0.001). Results were independent of completeness of PFO closure at one year.
Conclusions:
In patients with paradoxical cerebral embolism, migraine headaches are more frequent than in the general population, and transcatheter closure of the PFO results in complete resolution or marked reduction in frequency of migraine headache.
Insights
Transcatheter closure of patent foramen ovale (PFO) significantly reduces migraine frequency in patients with paradoxical embolism. This PFO treatment offers complete resolution or marked improvement for many patients experiencing migraines.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Migraine headache prevalence is elevated in cryptogenic stroke patients with patent foramen ovale (PFO).
- Previous research indicates PFO closure may alleviate migraine symptoms.
Purpose of the Study:
- To evaluate the impact of transcatheter PFO closure on migraine frequency.
- To assess migraine symptom changes in patients with paradoxical cerebral embolism post-PFO closure.
Main Methods:
- 162 patients with paradoxical embolism underwent transcatheter PFO closure (2001-2003).
- A one-year retrospective analysis compared migraine symptoms before and after PFO closure.
Main Results:
- 35% of patients had active migraine; 68% experienced aura.
- 56% of analyzed patients achieved complete migraine resolution; 14% had a significant reduction.
- Mean monthly migraine episodes decreased by 80% post-PFO closure (p < 0.001).
Conclusions:
- Migraine headaches are more common in patients with paradoxical embolism.
- Transcatheter PFO closure effectively resolves or significantly reduces migraine headache frequency in these patients.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Angle Closure Glaucoma: Treatment

